Physician profile
David Rivera
NPI 1851334262
$2,097.03
in general payments reported to CMS, 2019-2025
14 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $325 · 2021: $374 · 2022: $334 · 2023: $264 · 2024: $220 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,049.24 | 2019-2025 | Mavyret, Rinvoq, Botox |
| Janssen Pharmaceuticals, INC | $229.21 | 2019-2024 | Stelara |
| E.R. Squibb & Sons, L.L.C. | $199.17 | 2021-2024 | Zeposia |
| Gilead Sciences, INC. | $116.64 | 2020-2022 | |
| Genentech USA, INC. | $93.60 | 2020 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $87.44 | 2024-2025 | Omvoh |
| Ferring Pharmaceuticals INC. | $75.65 | 2019 | |
| Olympus Latin America, INC. | $70.57 | 2021 | |
| Intercept Pharmaceuticals, INC. | $51.08 | 2020-2025 | |
| Exact Sciences Corporation | $46.53 | 2024-2025 | Cologuard Collection Kit |
| Madrigal Pharmaceuticals | $27.78 | 2025 | Rezdiffra |
| Merck Sharp & Dohme LLC | $18.67 | 2019 | |
| Amgen INC. | $17.01 | 2021 | |
| Pbg Puerto Rico LLC | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.